-Hans D Ochs Researcher Activity Profile

Research Author Detailed Information 

Hans D Ochs Publication Rate By Year

Hans D Ochs has published 2 paper(s) in 2006, 19 paper(s) in 2007, for a total of 21 research publications in total.

Hans D Hd Ochs Author Information

LAST NAME: ochs

FIRST NAME: Hans D

INITIALS: hd

AFFILIATION:

Papers

Hans D Ochs's Publication Record

1. Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion. Year Published: 2006
Infectious and Inflammatory Disease Research Center, Burnham Institute for Biomedical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
2. Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice. Year Published: 2006
Children's Hospital and Regional Medical Center, Department of Pediatrics, University of Washington, Seattle, WA 98109, USA. miao@u.washington.edu
3. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Year Published: 2007
Division of Immunology, Infectious Diseases, Rheumatology, Children's Hospital and University of Washington, 307 Westlake Ave. North, Suite 300 (CW), Seattle, WA 98109, USA. allgau@u.washington.edu
4. Images in immunodeficiency. Year Published: 2007
Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA. wtsheare@TexasChildrensHospital.org
5. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Year Published: 2007
University of Washington & Children's Hospital, Department of Pediatrics, Division of Immunology, Rheumatology, & Infectious Diseases, Seattle, Washington, USA.
6. Transcellular diapedesis is initiated by invasive podosomes. Year Published: 2007
The CBR Institute for Biomedical Research, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
7. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. Year Published: 2007
Laboratory of Biochemistry and Molecular Immunology, Hospital for Special Surgery, New York, NY 10021, USA.
8. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
9. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Year Published: 2007
Division of Immunology, Infectious Diseases, Rheumatology, Children's Hospital and University of Washington, 307 Westlake Ave. North, Suite 300 (CW), Seattle, WA 98109, USA. allgau@u.washington.edu
10. Images in immunodeficiency. Year Published: 2007
Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA. wtsheare@TexasChildrensHospital.org
11. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Year Published: 2007
Division of Immunology, Children's Hospital, Boston, MA 02115, USA. faif.geha@childrens.harvard.edu
12. Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes. Year Published: 2007
Institute of Immunology, University Hospital Motol, V Uvalu 84, 150 06, Prague 5, Czech Republic, anna.sediva@fnmotol.cz.
13. Developmental changes of FOXP3-expressing CD4(+)CD25(+) regulatory T cells and their impairment in patients with FOXP3 gene mutations. Year Published: 2007
Department of Pediatrics, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.
14. Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations. Year Published: 2007
Department of Pediatrics, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
15. Wiskott-Aldrich syndrome. Year Published: 2007
Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA, USA.
16. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Year Published: 2007
Division of Immunology, Infectious Diseases, Rheumatology, Children's Hospital and University of Washington, 307 Westlake Ave. North, Suite 300 (CW), Seattle, WA 98109, USA. allgau@u.washington.edu
17. Wiskott-Aldrich syndrome. Year Published: 2007
Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA, USA.
18. Regulatory T cells in primary immunodeficiency diseases. Year Published: 2007
Division of Pediatric Immunology, Rheumatology and Infectious Diseases, University of Washington School of Medicine, Children's Hospital, Seattle, Washington, USA.
19. Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations. Year Published: 2007
Department of Pediatrics, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
20. Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. Year Published: 2007
Institute of Immunology, University Hospital Motol, V Uvalu 84, 150 06, Prague 5, Czech Republic. anna.sediva@fnmotol.cz
21. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy. Year Published: 2007
Department of Laboratory Medicine, Section of Clinical Immunology, F 79 Karolinska Institutet at Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. ann.gardulf@ki.se